Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Glimelius

Showing results (361-370 of 416) with videos related to

Pageof 42
Sort By:
Cancer|December 24, 1997
Objective responses after fractionated infusional brachytherapy of unresectable pancreatic adenocarcinomasJ E Westlin, C Andersson-Forsman, U Garske, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2009
A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancerC Qvortrup, B V Jensen, T Fokstuen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2008
Treatment of the elderly colorectal cancer patient: SIOG expert recommendationsD Papamichael, R Audisio, J-C Horiot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2008
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancerB Glimelius, H Sørbye, L Balteskard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancerB Glimelius, K Ekström, K Hoffman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trialsG Folprecht, D Cunningham, P Ross, et al.
Cancer Research|February 11, 1999
Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomavirusesM Frisch, C Fenger, A J van den Brule, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancerB Glimelius, R Ristamäki, M Kjaer, et al.
Journal of the National Cancer Institute|December 1, 1993
Second cancers among long-term survivors of non-Hodgkin's lymphomaL B Travis, R E Curtis, B Glimelius, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2010
Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancerC Frederiksen, C Qvortrup, I J Christensen, et al.
Pageof 42

Showing results (361-370 of 416) with videos related to

Sort By:
Pageof 42
Cancer|December 24, 1997
Objective responses after fractionated infusional brachytherapy of unresectable pancreatic adenocarcinomasJ E Westlin, C Andersson-Forsman, U Garske, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2009
A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancerC Qvortrup, B V Jensen, T Fokstuen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2008
Treatment of the elderly colorectal cancer patient: SIOG expert recommendationsD Papamichael, R Audisio, J-C Horiot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2008
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancerB Glimelius, H Sørbye, L Balteskard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancerB Glimelius, K Ekström, K Hoffman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trialsG Folprecht, D Cunningham, P Ross, et al.
Cancer Research|February 11, 1999
Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomavirusesM Frisch, C Fenger, A J van den Brule, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancerB Glimelius, R Ristamäki, M Kjaer, et al.
Journal of the National Cancer Institute|December 1, 1993
Second cancers among long-term survivors of non-Hodgkin's lymphomaL B Travis, R E Curtis, B Glimelius, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2010
Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancerC Frederiksen, C Qvortrup, I J Christensen, et al.
Pageof 42